Lung cancer

Open Access
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
JIRI BLAZEK, PETR HOSEK, KAROLINA HRABCOVA, MONIKA BRATOVA, JURAJ KULTAN, MICHAL HRNCIARIK, MARKETA CERNOVSKA, PETRA ZEMANOVA, JANA KREJCI, LEONA KOUBKOVA, MAREK STASTNY and MARTIN SVATON

In Vivo September 2023, 37 (5) 2229-2236; DOI: https://doi.org/10.21873/invivo.13324
Open Access
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study
KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO and HIDEKI SATO

In Vivo September 2023, 37 (5) 2260-2267; DOI: https://doi.org/10.21873/invivo.13328
Open Access
The Association of DNA Ligase 1 Rs20579 Polymorphism With Lung Cancer Risk Among Taiwanese
SHANG-MIAO CHANG, YA-CHEN YANG, GUAN-LIANG CHEN, LI-HSIOU CHEN, TE-CHUN SHEN, YEN-FENG LIU, YUN-CHI WANG, CHIA-WEN TSAI, TE-CHUN HSIA, DA-TIAN BAU and WEN-SHIN CHANG

In Vivo July 2023, 37 (4) 1504-1510; DOI: https://doi.org/10.21873/invivo.13235
Open Access
Expression of Three Clones of PD-L1 in Lung Cancer: A Single-center Experience
SANG-GON PARK, HEE JEONG LEE, SEUL BI LEE and RAN HONG

In Vivo January 2023, 37 (1) 233-241; DOI: https://doi.org/10.21873/invivo.13072
Open Access
Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years
ELISA M. WERNER, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and DIRK RADES

In Vivo May 2022, 36 (3) 1297-1301; DOI: https://doi.org/10.21873/invivo.12830
You have access
The Role of Programmed Cell Death Receptor 1 in Lung Cancer
DUMITRU CRISTINEL BADIU, ANCA ZGURA, CLAUDIA MEHEDINTU, BOGDAN HAINEALA, RODICA ANGHEL and XENIA BACINSCHI

In Vivo March 2022, 36 (2) 1007-1012; DOI: https://doi.org/10.21873/invivo.12794
You have access
Combination Treatment of Sorafenib and Bufalin Induces Apoptosis in NCI-H292 Human Lung Cancer Cells In Vitro
JUNG-YU KUO, CHING-LUNG LIAO, YI-SHIH MA, CHAO-LIN KUO, JAW-CHYUN CHEN, YI-PING HUANG, WEN-WEN HUANG, SHU-FEN PENG and JING-GUNG CHUNG

In Vivo March 2022, 36 (2) 582-595; DOI: https://doi.org/10.21873/invivo.12741
You have access
The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19
IPHIGENIA GINTONI, MARIA ADAMOPOULOU and CHRISTOS YAPIJAKIS

In Vivo January 2022, 36 (1) 13-29; DOI: https://doi.org/10.21873/invivo.12672
You have access
Relationship Between Radiation Pneumonitis Following Definitive Radiotherapy for Non-small Cell Lung Cancer and Isodose Line
SHIGENOBU WATANABE, ICHIRO OGINO, DAISUKE SHIGENAGA and MASAHARU HATA

In Vivo November 2021, 35 (6) 3441-3448; DOI: https://doi.org/10.21873/invivo.12644
You have access
Traditional Chinese Medicine Xihuang Wan Inhibited Lewis Lung Carcinoma in a Syngeneic Model, Equivalent to Cytotoxic Chemotherapy, by Altering Multiple Signaling Pathways
ZHIYING ZHANG, JIANFENG WANG, HUA DUAN, DIANNA LIU, XIANGNAN ZHOU, XIMING LIN, HAOYUE PANG, MANQIANG SUN, TIAN ZHOU, ROBERT M. HOFFMAN and KAIWEN HU

In Vivo July 2021, 35 (4) 2005-2014; DOI: https://doi.org/10.21873/invivo.12469

Main menu

User menu

Search

Lung cancer

Pages